Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Olympus ( (JP:7733) ).
Olympus is advancing a global personnel optimization program under its new corporate strategy, targeting workforce reductions across the parent company and group entities. The initiative applies to employees meeting set criteria and is scheduled from the fiscal year ending March 2026 through the fiscal year ending March 2027.
As of April 30, 2026, Olympus has cut 1,687 of the planned 2,000 positions worldwide, indicating substantial progress toward its restructuring goals. The program is expected to cost about JPY 32 billion, largely booked as other expenses over fiscal years 2026 and 2027, and aims to deliver annualized cost savings of roughly JPY 24 billion, potentially strengthening the firm’s profitability and operational efficiency.
The most recent analyst rating on (JP:7733) stock is a Hold with a Yen1700.00 price target. To see the full list of analyst forecasts on Olympus stock, see the JP:7733 Stock Forecast page.
More about Olympus
Olympus Corporation is a Japan-based manufacturer best known for its medical and scientific equipment, including endoscopes and imaging solutions. The company operates globally and is listed on the Tokyo Stock Exchange, focusing on improving efficiency and competitiveness within the medical technology sector.
Average Trading Volume: 6,650,062
Technical Sentiment Signal: Sell
Current Market Cap: Yen1730B
See more data about 7733 stock on TipRanks’ Stock Analysis page.